Limit use of J&J vaccine due to risk of blood clots

The FDA announced that it will limit the emergency use authorization of Johnson & Johnson’s COVID-19 vaccine to people 18 years of age and older.

In an FDA statement, it was reported that the change is motivated by the risk of a rare and dangerous clotting condition called thrombosis with thrombocytopenia syndrome, which can occur after receiving the vaccine.

The agency confirmed that the updated authorization also applies to booster doses.

–

–